Spero Therapeutics, Inc.
General ticker "SPRO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.3M (TTM average)
Spero Therapeutics, Inc. follows the US Stock Market performance with the rate: 38.5%.
Estimated limits based on current volatility of 2.1%: low 2.23$, high 2.32$
Factors to consider:
- Total employees count: 46 (+31.4%) as of 2023
- Top business risk factors: Inability to establish sales force, Market competition, Operational and conduct risks, Climate change and natural disasters, Litigation risks
- Current price 25.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.68$, 1.82$]
- 2025-12-31 to 2026-12-31 estimated range: [0.77$, 2.01$]
Financial Metrics affecting the SPRO estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -44.21 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 41.72 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SPRO quotes
Long-term SPRO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $48.58MM | $103.78MM | $47.98MM |
| Operating Expenses | $90.78MM | $82.30MM | $121.34MM |
| Operating Income | $-42.20MM | $21.48MM | $-73.36MM |
| Non-Operating Income | $-4.22MM | $3.92MM | $4.79MM |
| Interest Expense | $2.60MM | $0.00MM | $0.00MM |
| R&D Expense | $47.59MM | $51.44MM | $96.76MM |
| Income(Loss) | $-46.41MM | $25.40MM | $-68.57MM |
| Taxes | $0.00MM | $2.60MM | $0.00MM |
| Profit(Loss)* | $-46.41MM | $22.81MM | $-68.57MM |
| Stockholders Equity | $75.93MM | $106.89MM | $46.12MM |
| Inventory | $4.46MM | $0.00MM | $0.00MM |
| Assets | $124.80MM | $182.39MM | $110.54MM |
| Operating Cash Flow | $-7.73MM | $-32.99MM | $-23.44MM |
| Investing Cash Flow | $33.81MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $-29.55MM | $0.22MM | $0.00MM |
| Earnings Per Share** | $-1.23 | $0.43 | $-1.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.